OPADOfferpad Solutions Inc.
The schedule
- Thu15Oct
Review of Nasdaq minimum valuation of listed securities (MVLS) compliance given micro-cap status.
- Wed3Feb
Q3 2026 results reflecting the company's ability to capitalize on lower mortgage rates.
- Thu29Apr
Q1 2027 earnings indicating the strength of the spring selling season.
- Sun9May
Q4 2026 and full-year results detailing survival runway and potential path to positive net income.
Past
- Wed30Sep
Evaluation of potential equity dilution or new debt facilities needed to sustain operations.
- Mon3Aug
Actual outcome: Bull · $4.79 at outcome
Despite missing revenue estimates and reporting a net loss for the quarter, Offerpad announced multi-year high margins and accelerating signings, signaling that its 'buying engine is back on.' This positive operational momentum allowed the stock to resist a broader real estate selloff and rally 31.2% following the earnings release.
Q2 2026 earnings report addressing massive revenue contraction and debt reduction strategy.
- Wed15Jul
Actual outcome: Bear · $3.87 at outcome
Offerpad lacked substantive fundamental updates during the period, only announcing its Q2 earnings release date for August 3rd. With investors waiting on the sidelines for these upcoming results and competitors like Opendoor drawing more market interest, the stock experienced a muted 2.8% decline, resulting in a mixed outcome.
Market evaluation of summer housing velocity following a likely reverse split.
- Thu30Apr
Actual outcome: Mixed · $8.20 at outcome
Offerpad reported Q1 2026 EPS of -$2.20, exactly meeting analyst estimates and signaling that unit volumes and contribution margins were stabilizing after previous revenue contractions. This in-line performance and disciplined inventory management reassured investors, driving the stock to significantly exceed the $1.05 bull target.
Q1 2026 earnings and guidance will show whether Offerpad’s unit volumes and margins are stabilizing after revenue fell to $114.1M in Q4 2025, with the stock near $0.81; a clean quarter with improving contribution margins and disciplined inventory could re-rate shares toward $1.05, while further revenue contraction or wider losses could push the stock down toward $1.05.
